Thyroglobulin Antibody Test

Thyroglobulin antibodies (TgAb) are autoantibodies—immune proteins that mistakenly target and bind to thyroglobulin, a key protein used by the thyroid gland to produce thyroid hormones. The presence of TgAb is a hallmark of autoimmune thyroid conditions, particularly Hashimoto’s thyroiditis and, less commonly, Graves’ disease.

In a healthy thyroid, thyroglobulin is stored inside the follicles of the gland and acts as a scaffold for building T3 and T4, the two primary thyroid hormones. When the immune system begins producing TgAb, it treats this protein as a threat, triggering inflammation and gradual damage to the thyroid. Over time, this autoimmune attack can lead to hypothyroidism—a state where the gland can no longer produce enough hormone to meet the body’s needs.

TgAb is typically measured as part of a broader panel of antithyroid antibodies, often alongside thyroid peroxidase antibodies (TPOAb). While TPOAb is more commonly positive in autoimmune thyroid disease, the presence of TgAb still offers important diagnostic and prognostic information. For instance, people with both TgAb and TPOAb are more likely to develop overt hypothyroidism over time compared to those with only one type of antibody.

Importantly, TgAb can be present years before thyroid function declines. Its detection in someone with borderline or subclinical hypothyroidism suggests a higher risk of progression to full-blown thyroid failure. Even in individuals with normal TSH and thyroid hormone levels, the presence of TgAb may indicate that the immune system has already begun targeting thyroid tissue, warranting periodic monitoring of thyroid function.

It’s also worth noting that TgAb does not cause symptoms on its own. Many people with TgAb feel fine and have normal thyroid hormone levels. However, if symptoms such as fatigue, weight gain, constipation, or sensitivity to cold appear, repeat thyroid testing may be indicated—even if previous results were normal.